Try our Chrome extension
Easily add the current web-page from your browser directly into your changedetection.io tool, more great features coming soon!
Chrome Webstore
Changedetection.io needs your support!
You can help us by supporting changedetection.io on these platforms;
- Rate us at AlternativeTo.net
- Star us on GitHub
- Follow us at Twitter/X
- Check us out on LinkedIn
- And tell your friends and colleagues :)
The more popular changedetection.io is, the more time we can dedicate to adding amazing features!
Many thanks :)
changedetection.io team
Not yet seconds ago
False
Not yet seconds ago
3 weeks ago
Pro-tip: Highlight text to add to ignore filters
Innovation for life Sofinnova
* Purpose
* People
* Portfolio
* Platforms
* Press
Sofinnova
* Purpose
* People
* Portfolio
* Platforms
* Press
* Careers
* Contact
* Investor Portal
Innovation
for Life.
How do some of the world’s most transformative biotechs go from inception to reality? With Sofinnova. We forge the path. From drug development and the regulatory process, to company building and IPO. Sofinnova is a collaborative, experienced partner with you through every phase of your growth.
Learn more about our team »
Funding
Tomorrow’s
Cures.
Where do life science, finance, and innovation meet? At Sofinnova, where we deploy human and financial capital to turn dreams into drugs.
Transformative Impact
115
Companies Funded
53
IPOs
30
M&As
31
FDA Drugs
Approved
120
Years Operating
Experience
100
Years Investing
Experience
Our Impact
Binding Science & Innovation
We team with world class entrepreneurs who want to change life through medicine. With tools and experience to guide them, Sofinnova is helping entrepreneurs challenge the status quo of medical care, advancing cures, and improving lives.
Our Portfolio
Featured Press
View all Press
Perspectives Feb 20, 2025
Maha Radhakrishnan Shares Insights with NYSE “We’re Cure(ious) About the Future of Healthcare” Series
link
Perspectives Feb 14, 2025
Jakob Dupont Highlighted in “Key takeaways from the JP Morgan Healthcare Conference”
link
Portfolio News Feb 12, 2025
OnCusp Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer
link
View all Press
There’s No Time To Waste
When it comes to our mission, we get down to the business of funding cures. Sofinnova doesn’t just mean capital. Innovators partner with us because we have the tools to guide them through every step of effecting hope through biopharmaceuticals.
Our Team
Sofinnova
3000 Sand Hill Rd
Building 3-Suite 150
Menlo Park, CA 94025
(650) 681-8420
One Marina Park Drive
Suite 300
Boston, MA 02210
27 West 24th Street
Suite 302
New York, NY 10010
© 2025 Sofinnova | Privacy Policy
*As of 6/30/2024 Sofinnova records unaudited and subject to change.
|
For now, Differences are performed on text, not graphically, only the latest screenshot is available.
Screenshot requires Playwright/WebDriver enabled